Laboratory Medicine ›› 2023, Vol. 38 ›› Issue (4): 399-402.DOI: 10.3969/j.issn.1673-8640.2023.04.019
Previous Articles Next Articles
Received:2022-05-15
Revised:2022-07-28
Online:2023-04-28
Published:2023-06-21
CLC Number:
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.shjyyx.com/EN/10.3969/j.issn.1673-8640.2023.04.019
| 1. |
BROWN-ELLIOTT B A, BROWN J M, CONVILLE P S, et al. Clinical and laboratory features of the Nocardia spp. based on current molecular taxonomy[J]. Clin Microbiol Rev, 2006, 19(2):259-282.
DOI URL |
| 2. | PELAEZ A I, GARCIA-SUAREZ MDEL M, MANTECA A, et al. A fatal case of Nocardia otitidiscaviarum pulmonary infection and brain abscess:taxonomic characterization by molecular techniques[J]. Ann Clin MicrobiolAntimicrob, 2009, 8:11. |
| 3. |
SAUBOLLE M A, SUSSLAND D. Nocardiosis:review of clinical and laboratory experience[J]. J Clin Microbiol, 2003, 41(10):4497-4501.
DOI URL |
| 4. | GUERRA A C, BATISTA D, ALEIXO M J, et al. Disseminated nocardiosis:a successful blind strategy of treatment in an HIV infected patient[J]. Case Rep Infect Dis, 2015, 2015:260640. |
| 5. |
PAIGE E K, SPELMAN D. Nocardiosis:7-year experience at an Australian tertiary hospital[J]. Intern Med J, 2019, 49(3):373-379.
DOI URL |
| 6. |
AMBROSIONI J, LEW D, GARBINO J. Nocardiosis:updated clinical review and experience at a tertiary center[J]. Infection, 2010, 38(2):89-97.
DOI URL |
| 7. |
JIANG Y, HUANG A, FANG Q. Disseminated nocardiosis caused by Nocardia otitidiscaviarum in an immunocompetent host:a case report and literature review[J]. Exp Ther Med, 2016, 12(5):3339-3346.
DOI URL |
| 8. |
MEHRIAN P, ESFANDIARI E, KARIMI M A, et al. Computed tomography features of pulmonary nocardiosis in immunocompromised and immunocompetent patients[J]. Pol J Radiol, 2015, 80:13-17.
DOI URL |
| 9. | 杨柳, 马迎民. 肺豚鼠耳炎诺卡菌病1例[J]. 中华老年多器官疾病杂志, 2016, 15(9):697-699. |
| 10. |
UHDE K B, PATHAK S, MCCULLUM I Jr, et al. Antimicrobial-resistant Nocardia isolates,United States,1995-2004[J]. Clin Infect Dis, 2010, 51(12):1445-1448.
DOI URL |
| 11. |
CLARK N M, REID G E, AST Infectious Diseases Community of Practice. Nocardia infections in solid organ transplantation[J]. Am J Transplant, 2013, 13(Suppl 4):83-92.
DOI URL |
| 12. |
DEEPA R, BANU S T, JAYALAKSHMI G, et al. Pleuropulmonary nocardiosis due to Nocardia otitidiscaviarum in a debilitated host[J]. Indian J Pathol Microbiol, 2016, 59(2):240-242.
DOI URL |
| 13. |
AMIN A, MAHMOOD S F, ANIS M, et al. Pulmonary nocardiosis:a comparative analysis of Nocardia asteroides and non-asteroides species[J]. Trop Doct, 2012, 42(2):94-96.
DOI URL |
| 14. | 林思琪, 方勇, 叶联毅, 等. 豚鼠耳炎诺卡菌肺病2例并文献复习[J]. 临床肺科杂志, 2022, 27(6):959-961. |
| 15. | SCHEELJE CARABELLI T, ESTEBAN RONDA V, HERNÁNDEZ MORENO K. Nocardia otitidiscaviarum infection in an immunocompetent patient[J]. Arch Bronconeumol(Engl Ed), 2018, 55(1):59-60. |
| 16. | 余方颖, 胡权铖, 刘璐璐, 等. 肺部豚鼠耳炎诺卡菌感染一例并文献复习[J]. 中国呼吸与危重监护杂志, 2022, 21(3):200-204. |
| 17. | 沈轶, 张海, 李锋, 等. 豚鼠耳炎诺卡菌肺病一例并文献复习[J]. 国际呼吸杂志, 2020, 40(12):897-903. |
| [1] | FAN Lieying. Research status and application prospects of biomarkers for membranous nephropathy [J]. Laboratory Medicine, 2023, 38(12): 1111-1114. |
| [2] | SUN Lincheng, LI Jianfeng, CHENG Weili, JI Panyun. Roles of anti-PLA2R IgG4 antibody and PLA2R IgG4/IgG ratio in primary membranous nephropathy [J]. Laboratory Medicine, 2023, 38(12): 1115-1120. |
| [3] | LIU Qingyang, YUAN Jianming, XIA Jinjun, JIANG Fengying, WANG Qiubo, WANG Xiaoming. CXCL9 as a potential diagnostic marker of rheumatoid arthritis based on GEO database and experimental verification [J]. Laboratory Medicine, 2023, 38(12): 1121-1129. |
| [4] | YANG Xiao, LI Enling, WU Lixia, DAI Yingxin, WANG Zhiqing, HUANG Hao, ZHENG Bing. Influence of cytoplasmic antinuclear antibody on indirect immunofluorescence assay based antineutrophil cytoplasmic antibody determination [J]. Laboratory Medicine, 2023, 38(12): 1135-1140. |
| [5] | XIANG Jin, LIU Aiping, HU Yao, WU Zhiyuan, CAO Guojun, GUAN Ming. ANA profiles in COVID-19 patients and influence of serum heat-inactivation on ANA determination [J]. Laboratory Medicine, 2023, 38(12): 1141-1146. |
| [6] | CHENG Yu, XU Zhen, LU Liu, DING Menglei, YU Shanshan, ZONG Ming, FAN Lieying. Expression and risk factors of anti-ACE-2 antibody in serum of patients with COVID-19 [J]. Laboratory Medicine, 2023, 38(12): 1147-1152. |
| [7] | . [J]. Laboratory Medicine, 2023, 38(12): 1153-1156. |
| [8] | . [J]. Laboratory Medicine, 2023, 38(12): 1157-1159. |
| [9] | WANG Hongling, LIU Mengna, BAI Ping, LIAO Huanjin. Risk factors of relapse following allogeneic hematopoietic stem cell transplantation in patients with acute myeloid leukemia [J]. Laboratory Medicine, 2023, 38(12): 1160-1166. |
| [10] | YANG Xilan, WANG Jinyu, LIU Shuyu, ZHAN Yiyang, LIU Jing, JIA Jian. Correlation between hyperlipidemia and endothelial microparticles in elderly patients from Gulou Community in Nanjing [J]. Laboratory Medicine, 2023, 38(12): 1167-1172. |
| [11] | DAI Fangfang, LU Xinxin, YU Yanhua, CHEN Ming, SUN Guizhen. Analysis of Mycobacterium infection in HIV/AIDS patients [J]. Laboratory Medicine, 2023, 38(12): 1173-1176. |
| [12] | GU Yu, LIANG Xiaoyan, MA Shenghui, TONG Na, CHENG Mingyan, YAN Zejun. Expression and near-term prognostic predictive value of plasma biomarkers in chronic kidney disease patients with thromboembolism [J]. Laboratory Medicine, 2023, 38(12): 1177-1182. |
| [13] | . [J]. Laboratory Medicine, 2023, 38(12): 1183-1185. |
| [14] | . [J]. Laboratory Medicine, 2023, 38(12): 1186-1190. |
| [15] | . [J]. Laboratory Medicine, 2023, 38(12): 1191-1194. |
| Viewed | ||||||
|
Full text |
|
|||||
|
Abstract |
|
|||||
